RelabotulinumtoxinA Treatment Improved Moderate to Severe Glabellar Lines and Lateral Canthal Lines Regardless of Baseline Toxin Naivety: Subgroup Analyses of Pooled Phase 3 Study Data

Toxicon 2026

View at publisher

Authors: Sue Ellen Cox, Michael Gold, Sachin M. Shridharani, Melanie D. Palm, Lisa D. Grunebaum, Mark S. Nestor, Inna Prygova

DOI: 10.1016/j.toxicon.2025.108718

Cited by: 0

Fields of Study & Subjects

Botulinum Toxin and Related Neurological Disorders Pain Mechanisms and Treatments Trigeminal Neuralgia and Treatments